{
  "DOI": "10.1038/s41431-022-01107-9",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-022-01107-9",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eThe association between severe mental illness (SMI) and cardiovascular and metabolic disease (CMD) is poorly understood. \u003cjats:italic\u003ePCSK9\u003c/jats:italic\u003e is expressed in systems critical to both SMI and CMD and influences lipid homeostasis and brain function. We systematically investigated relationships between genetic variation within the \u003cjats:italic\u003ePCSK9\u003c/jats:italic\u003e locus and risk for both CMD and SMI. UK Biobank recruited ~500,000 volunteers and assessed a wide range of SMI and CMD phenotypes. We used genetic data from white British ancestry individuals of UK Biobank. Genetic association analyses were conducted in PLINK, with statistical significance defined by the number of independent SNPs. Conditional analyses and linkage disequilibrium assessed the independence of SNPs and the presence of multiple signals. Two genetic risk scores of lipid-lowering alleles were calculated and used as proxies for putative lipid-lowering effects of PCSK9. \u003cjats:italic\u003ePCSK9\u003c/jats:italic\u003e variants were associated with central adiposity, venous thrombosis embolism, systolic blood pressure, mood instability, and neuroticism (all \u003cjats:italic\u003ep\u003c/jats:italic\u003e \u0026lt; 1.16 × 10\u003cjats:sup\u003e−4\u003c/jats:sup\u003e). No secondary signals were identified. Conditional analyses and high linkage disequilibrium (\u003cjats:italic\u003er\u003c/jats:italic\u003e\u003cjats:sup\u003e\u003cjats:italic\u003e2\u003c/jats:italic\u003e\u003c/jats:sup\u003e = 0.98) indicated that mood instability and central obesity may share a genetic signal. Genetic risk scores suggested that the lipid-lowering effects of \u003cjats:italic\u003ePCSK9\u003c/jats:italic\u003e may be causal for greater mood instability and higher neuroticism. This is the first study to implicate the \u003cjats:italic\u003ePCSK9\u003c/jats:italic\u003e locus in mood-disorder symptoms and related traits, as well as the shared pathology of SMI and CMD\u003cjats:italic\u003e. PCSK9\u003c/jats:italic\u003e effects on mood may occur via lipid-lowering mechanisms. Further work is needed to understand whether repurposing PCSK9-targeting therapies might improve SMI symptoms and prevent CMD.\u003c/jats:p\u003e",
  "alternative-id": [
    "1107"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "31 October 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "11 January 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "12 April 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "2 May 2022"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors have no competing interests."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Generic ethical approval granted by the NHS National Research Ethics Service (approval letter dated 13 May 2016, Ref 16/NW/0274)."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Hay",
      "given": "Rachel",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Cullen",
      "given": "Breda",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Graham",
      "given": "Nicholas",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lyall",
      "given": "Donald M.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-4022-5880",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Aman",
      "given": "Alisha",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pell",
      "given": "Jill P.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ward",
      "given": "Joey",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Smith",
      "given": "Daniel J.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-8506-3585",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Strawbridge",
      "given": "Rona J.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        5,
        2
      ]
    ],
    "date-time": "2022-05-02T09:02:58Z",
    "timestamp": 1651482178000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        12,
        1
      ]
    ],
    "date-time": "2022-12-01T01:05:13Z",
    "timestamp": 1669856713000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        28
      ]
    ],
    "date-time": "2024-03-28T01:17:19Z",
    "timestamp": 1711588639151
  },
  "is-referenced-by-count": 7,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "12",
  "issued": {
    "date-parts": [
      [
        2022,
        5,
        2
      ]
    ]
  },
  "journal-issue": {
    "issue": "12",
    "published-print": {
      "date-parts": [
        [
          2022,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            5,
            2
          ]
        ],
        "date-time": "2022-05-02T00:00:00Z",
        "timestamp": 1651449600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            5,
            2
          ]
        ],
        "date-time": "2022-05-02T00:00:00Z",
        "timestamp": 1651449600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-022-01107-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01107-9",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01107-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1380-1390",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2022,
        5,
        2
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        5,
        2
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3390/healthcare2020166",
      "author": "T Bradshaw",
      "doi-asserted-by": "publisher",
      "first-page": "166",
      "journal-title": "Healthc (Basel)",
      "key": "1107_CR1",
      "unstructured": "Bradshaw T, Mairs H. Obesity and serious mental ill health: a critical review of the literature. Healthc (Basel). 2014;2:166–82.",
      "volume": "2",
      "year": "2014"
    },
    {
      "DOI": "10.1002/j.2051-5545.2011.tb00014.x",
      "author": "M De Hert",
      "doi-asserted-by": "publisher",
      "first-page": "52",
      "journal-title": "World Psychiatry",
      "key": "1107_CR2",
      "unstructured": "De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10:52–77.",
      "volume": "10",
      "year": "2011"
    },
    {
      "author": "O Abosi",
      "first-page": "1",
      "journal-title": "Horm Mol Biol Clin Investig",
      "key": "1107_CR3",
      "unstructured": "Abosi O, Lopes S, Schmitz S, Fiedorowicz JG. Cardiometabolic effects of psychotropic medications. Horm Mol Biol Clin Investig. 2018;36:1–15.",
      "volume": "36",
      "year": "2018"
    },
    {
      "DOI": "10.1038/tp.2016.261",
      "author": "AT Amare",
      "doi-asserted-by": "publisher",
      "journal-title": "Transl Psychiatry",
      "key": "1107_CR4",
      "unstructured": "Amare AT, Schubert KO, Klingler-Hoffmann M, Cohen-Woods S, Baune BT. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Transl Psychiatry. 2017;7:e1007.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41398-017-0044-z",
      "author": "H Cao",
      "doi-asserted-by": "publisher",
      "journal-title": "Transl Psychiatry",
      "key": "1107_CR5",
      "unstructured": "Cao H, Chen J, Meyer-Lindenberg A, Schwarz E. A polygenic score for schizophrenia predicts glycemic control. Transl Psychiatry. 2017;7:1295.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41380-018-0017-5",
      "author": "Y Milaneschi",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "journal-title": "Mol Psychiatry",
      "key": "1107_CR6",
      "unstructured": "Milaneschi Y, Simmons WK, van Rossum EFC, Penninx BW. Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry. 2019;24:18–33.",
      "volume": "24",
      "year": "2019"
    },
    {
      "DOI": "10.1017/S0033291718001812",
      "author": "HC So",
      "doi-asserted-by": "publisher",
      "first-page": "1286",
      "journal-title": "Psychol Med",
      "key": "1107_CR7",
      "unstructured": "So HC, Chau KL, Ao FK, Mo CH, Sham PC. Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits. Psychol Med. 2019;49:1286–98.",
      "volume": "49",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s00395-017-0619-0",
      "author": "S Glerup",
      "doi-asserted-by": "publisher",
      "first-page": "32",
      "journal-title": "Basic Res Cardiol",
      "key": "1107_CR8",
      "unstructured": "Glerup S, Schulz R, Laufs U, Schluter KD. Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease. Basic Res Cardiol. 2017;112:32.",
      "volume": "112",
      "year": "2017"
    },
    {
      "DOI": "10.1161/CIRCRESAHA.114.301621",
      "author": "NG Seidah",
      "doi-asserted-by": "publisher",
      "first-page": "1022",
      "journal-title": "Circ Res",
      "key": "1107_CR9",
      "unstructured": "Seidah NG, Awan Z, Chretien M, Mbikay M. PCSK9: a key modulator of cardiovascular health. Circ Res. 2014;114:1022–36.",
      "volume": "114",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ajpath.2021.04.016",
      "author": "C Macchi",
      "doi-asserted-by": "publisher",
      "first-page": "1385",
      "journal-title": "Am J Pathol",
      "key": "1107_CR10",
      "unstructured": "Macchi C, Ferri N, Sirtori CR, Corsini A, Banach M, Ruscica M. Proprotein convertase subtilisin/kexin type 9: a view beyond the canonical cholesterol-lowering impact. Am J Pathol. 2021;191:1385–97.",
      "volume": "191",
      "year": "2021"
    },
    {
      "DOI": "10.1093/eurheartj/ehx144",
      "author": "BA Ference",
      "doi-asserted-by": "publisher",
      "first-page": "2459",
      "journal-title": "Eur Heart J",
      "key": "1107_CR11",
      "unstructured": "Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–72.",
      "volume": "38",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.jacl.2017.12.018",
      "author": "L Masana",
      "doi-asserted-by": "publisher",
      "first-page": "292",
      "journal-title": "J Clin Lipido",
      "key": "1107_CR12",
      "unstructured": "Masana L, Girona J, Ibarretxe D, Rodriguez-Calvo R, Rosales R, Vallve JC, et al. Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis. J Clin Lipido. 2018;12:292–299. e293",
      "volume": "12",
      "year": "2018"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.120.046290",
      "author": "Z Qi",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "journal-title": "Circulation",
      "key": "1107_CR13",
      "unstructured": "Qi Z, Hu L, Zhang J, Yang W, Liu X, Jia D, et al. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36. Circulation. 2021;143:45–61.",
      "volume": "143",
      "year": "2021"
    },
    {
      "DOI": "10.3390/ijms22137193",
      "author": "V Cammisotto",
      "doi-asserted-by": "publisher",
      "first-page": "7193",
      "journal-title": "Int J Mol Sci",
      "key": "1107_CR14",
      "unstructured": "Cammisotto V, Baratta F, Castellani V, Bartimoccia S, Nocella C, D’Erasmo L, et al. Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways. Int J Mol Sci. 2021;22:7193–205.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1194/jlr.CX00001-JLR200",
      "author": "AS Peterson",
      "doi-asserted-by": "publisher",
      "first-page": "1595",
      "journal-title": "J Lipid Res",
      "key": "1107_CR15",
      "unstructured": "Peterson AS, Fong LG, Young SG. PCSK9 function and physiology. J Lipid Res. 2008;49:1595–9.",
      "volume": "49",
      "year": "2008"
    },
    {
      "DOI": "10.3389/fnins.2020.00609",
      "author": "EM O’Connell",
      "doi-asserted-by": "publisher",
      "first-page": "609",
      "journal-title": "Front Neurosci",
      "key": "1107_CR16",
      "unstructured": "O’Connell EM, Lohoff FW. Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the brain and relevance for neuropsychiatric disorders. Front Neurosci. 2020;14:609.",
      "volume": "14",
      "year": "2020"
    },
    {
      "DOI": "10.3233/JAD-160411",
      "author": "F Zimetti",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "journal-title": "J Alzheimers Dis",
      "key": "1107_CR17",
      "unstructured": "Zimetti F, Caffarra P, Ronda N, Favari E, Adorni MP, Zanotti I, et al. Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease. J Alzheimers Dis. 2017;55:315–20.",
      "volume": "55",
      "year": "2017"
    },
    {
      "DOI": "10.1176/appi.ajp.2021.20101479",
      "author": "KT Watson",
      "doi-asserted-by": "publisher",
      "first-page": "914",
      "journal-title": "Am J Psychiatry",
      "key": "1107_CR18",
      "unstructured": "Watson KT, Simard JF, Henderson VW, Nutkiewicz L, Lamers F, Nasca C, et al. Incident major depressive disorder predicted by three measures of insulin resistance: a Dutch cohort study. Am J Psychiatry. 2021;178:914–20.",
      "volume": "178",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s12933-020-01158-6",
      "author": "C Macchi",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "Cardiovasc Diabetol",
      "key": "1107_CR19",
      "unstructured": "Macchi C, Favero C, Ceresa A, Vigna L, Conti DM, Pesatori AC, et al. Depression and cardiovascular risk-association among Beck Depression Inventory, PCSK9 levels and insulin resistance. Cardiovasc Diabetol. 2020;19:187.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1371/journal.pone.0220254",
      "author": "C Picard",
      "doi-asserted-by": "publisher",
      "first-page": "e0220254",
      "journal-title": "PLoS One",
      "key": "1107_CR20",
      "unstructured": "Picard C, Poirier A, Belanger S, Labonte A, Auld D, Poirier J, et al. Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: A genetic and proteomic multi-cohort study. PLoS One. 2019;14:e0220254.",
      "volume": "14",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.atherosclerosis.2021.06.913",
      "author": "MJ Janik",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "Atherosclerosis",
      "key": "1107_CR21",
      "unstructured": "Janik MJ, Urbach DV, van Nieuwenhuizen E, Zhao J, Yellin O, Baccara-Dinet MT, et al. Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study. Atherosclerosis. 2021;331:20–27.",
      "volume": "331",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s40264-020-01021-3",
      "author": "G di Mauro",
      "doi-asserted-by": "publisher",
      "first-page": "337",
      "journal-title": "Drug Saf",
      "key": "1107_CR22",
      "unstructured": "di Mauro G, Zinzi A, Scavone C, Mascolo A, Gaio M, Sportiello L, et al. PCSK9 inhibitors and neurocognitive adverse drug reactions: analysis of individual case safety reports from the eudravigilance database. Drug Saf. 2021;44:337–49.",
      "volume": "44",
      "year": "2021"
    },
    {
      "DOI": "10.1161/CIRCGEN.118.002196",
      "author": "CP Nelson",
      "doi-asserted-by": "publisher",
      "first-page": "e002196",
      "journal-title": "Circ Genom Precis Med",
      "key": "1107_CR23",
      "unstructured": "Nelson CP, Lai FY, Nath M, Ye S, Webb TR, Schunkert H, et al. Genetic assessment of potential long-term on-target side effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) inhibitors. Circ Genom Precis Med. 2019;12:e002196.",
      "volume": "12",
      "year": "2019"
    },
    {
      "author": "J Pott",
      "first-page": "999",
      "journal-title": "Hum Mol Genet",
      "key": "1107_CR24",
      "unstructured": "Pott J, Gadin J, Theusch E, Kleber ME, Delgado GE, Kirsten H, et al. Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2. Hum Mol Genet. 2021;6:999–1011.",
      "volume": "6",
      "year": "2021"
    },
    {
      "DOI": "10.1177/0891988718764330",
      "author": "M Paquette",
      "doi-asserted-by": "publisher",
      "first-page": "90",
      "journal-title": "J Geriatr Psychiatry Neurol",
      "key": "1107_CR25",
      "unstructured": "Paquette M, Saavedra YGL, Poirier J, Theroux L, Dea D, Baass A, et al. Loss-of-function PCSK9 mutations are not associated with Alzheimer disease. J Geriatr Psychiatry Neurol. 2018;31:90–96.",
      "volume": "31",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41586-018-0579-z",
      "author": "C Bycroft",
      "doi-asserted-by": "publisher",
      "first-page": "203",
      "journal-title": "Nature",
      "key": "1107_CR26",
      "unstructured": "Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–9.",
      "volume": "562",
      "year": "2018"
    },
    {
      "DOI": "10.1093/brain/awv335",
      "author": "PM Matthews",
      "doi-asserted-by": "publisher",
      "first-page": "3463",
      "journal-title": "Brain",
      "key": "1107_CR27",
      "unstructured": "Matthews PM, Sudlow C. The UK Biobank. Brain. 2015;138:3463–5.",
      "volume": "138",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.3667",
      "author": "GB Ehret",
      "doi-asserted-by": "publisher",
      "first-page": "1171",
      "journal-title": "Nat Genet",
      "key": "1107_CR28",
      "unstructured": "Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T, et al. The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet. 2016;48:1171–84.",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature14132",
      "author": "D Shungin",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "Nature",
      "key": "1107_CR29",
      "unstructured": "Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518:187–96.",
      "volume": "518",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0162388",
      "author": "SV Eastwood",
      "doi-asserted-by": "publisher",
      "first-page": "e0162388",
      "journal-title": "PLoS One",
      "key": "1107_CR30",
      "unstructured": "Eastwood SV, Mathur R, Atkinson M, Brophy S, Sudlow C, Flaig R, et al. Algorithms for the capture and adjudication of prevalent and incident diabetes in UK biobank. PLoS One. 2016;11:e0162388.",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1192/bjo.2019.100",
      "author": "KAS Davis",
      "doi-asserted-by": "publisher",
      "first-page": "e18",
      "journal-title": "BJPsych Open",
      "key": "1107_CR31",
      "unstructured": "Davis KAS, Coleman JRI, Adams M, Allen N, Breen G, Cullen B, et al. Mental health in UK Biobank - development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysis. BJPsych Open. 2020;6:e18.",
      "volume": "6",
      "year": "2020"
    },
    {
      "DOI": "10.1192/bjo.2018.19",
      "author": "KAS Davis",
      "doi-asserted-by": "publisher",
      "first-page": "136",
      "journal-title": "BJPsych Open",
      "key": "1107_CR32",
      "unstructured": "Davis KAS, Coleman JRI, Adams M, Allen N, Breen G, Cullen B, et al. Erratum: mental health in UK Biobank: development, implementation and results from an online questionnaire completed by 157 366 participants - CORRIGENDUM. BJPsych Open. 2018;4:136.",
      "volume": "4",
      "year": "2018"
    },
    {
      "DOI": "10.1086/519795",
      "author": "S Purcell",
      "doi-asserted-by": "publisher",
      "first-page": "559",
      "journal-title": "Am J Hum Genet",
      "key": "1107_CR33",
      "unstructured": "Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.",
      "volume": "81",
      "year": "2007"
    },
    {
      "DOI": "10.1093/bioinformatics/btq419",
      "author": "RJ Pruim",
      "doi-asserted-by": "publisher",
      "first-page": "2336",
      "journal-title": "Bioinformatics",
      "key": "1107_CR34",
      "unstructured": "Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336–7.",
      "volume": "26",
      "year": "2010"
    },
    {
      "DOI": "10.1093/bioinformatics/bth457",
      "author": "JC Barrett",
      "doi-asserted-by": "publisher",
      "first-page": "263",
      "journal-title": "Bioinformatics",
      "key": "1107_CR35",
      "unstructured": "Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5.",
      "volume": "21",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng.2653",
      "author": "Genotype-Tissue Expression Consortium.",
      "doi-asserted-by": "publisher",
      "first-page": "580",
      "journal-title": "Nat Genet",
      "key": "1107_CR36",
      "unstructured": "Genotype-Tissue Expression Consortium. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580–5.",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1093/bioinformatics/btx561",
      "author": "MJ Machiela",
      "doi-asserted-by": "publisher",
      "first-page": "887",
      "journal-title": "Bioinformatics",
      "key": "1107_CR37",
      "unstructured": "Machiela MJ, Chanock SJ. LDassoc: an online tool for interactively exploring genome-wide association study results and prioritizing variants for functional investigation. Bioinformatics. 2018;34:887–9.",
      "volume": "34",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s13059-016-0974-4",
      "author": "W McLaren",
      "doi-asserted-by": "publisher",
      "journal-title": "Genome Biol",
      "key": "1107_CR38",
      "unstructured": "McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The ensembl variant effect predictor. Genome Biol. 2016;17:122.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1126/science.1260419",
      "author": "M Uhlen",
      "doi-asserted-by": "publisher",
      "first-page": "1260419",
      "journal-title": "Science",
      "key": "1107_CR39",
      "unstructured": "Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.",
      "volume": "347",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s12872-019-1187-z",
      "author": "AF Schmidt",
      "doi-asserted-by": "publisher",
      "first-page": "240",
      "journal-title": "BMC Cardiovasc Disord",
      "key": "1107_CR40",
      "unstructured": "Schmidt AF, Holmes MV, Preiss D, Swerdlow DI, Denaxas S, Fatemifar G, et al. Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. BMC Cardiovasc Disord. 2019;19:240.",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.1056/NEJMoa1604304",
      "author": "BA Ference",
      "doi-asserted-by": "publisher",
      "first-page": "2144",
      "journal-title": "N Engl J Med",
      "key": "1107_CR41",
      "unstructured": "Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med. 2016;375:2144–53.",
      "volume": "375",
      "year": "2016"
    },
    {
      "DOI": "10.1055/s-0038-1676863",
      "author": "F Paciullo",
      "doi-asserted-by": "publisher",
      "first-page": "359",
      "journal-title": "Thromb Haemost",
      "key": "1107_CR42",
      "unstructured": "Paciullo F, Momi S, Gresele P. PCSK9 in haemostasis and thrombosis: possible pleiotropic effects of PCSK9 inhibitors in cardiovascular prevention. Thromb Haemost. 2019;119:359–67.",
      "volume": "119",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s11745-014-3895-6",
      "author": "YQ Chen",
      "doi-asserted-by": "publisher",
      "first-page": "445",
      "journal-title": "Lipids",
      "key": "1107_CR43",
      "unstructured": "Chen YQ, Troutt JS, Konrad RJ. PCSK9 is present in human cerebrospinal fluid and is maintained at remarkably constant concentrations throughout the course of the day. Lipids. 2014;49:445–55.",
      "volume": "49",
      "year": "2014"
    },
    {
      "DOI": "10.3390/ijms222011179",
      "author": "A Petersen-Uribe",
      "doi-asserted-by": "publisher",
      "first-page": "11179",
      "journal-title": "Int J Mol Sci",
      "key": "1107_CR44",
      "unstructured": "Petersen-Uribe A, Kremser M, Rohlfing AK, Castor T, Kolb K, Dicenta V, et al. Platelet-derived PCSK9 is associated with LDL metabolism and modulates atherothrombotic mechanisms in coronary artery disease. Int J Mol Sci. 2021;22:11179–91.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s12974-017-0991-6",
      "author": "H Martiskainen",
      "doi-asserted-by": "publisher",
      "journal-title": "J Neuroinflammation",
      "key": "1107_CR45",
      "unstructured": "Martiskainen H, Paldanius KMA, Natunen T, Takalo M, Marttinen M, Leskela S, et al. DHCR24 exerts neuroprotection upon inflammation-induced neuronal death. J Neuroinflammation. 2017;14:215.",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.3389/fnagi.2021.513605",
      "author": "X Bai",
      "doi-asserted-by": "publisher",
      "first-page": "513605",
      "journal-title": "Front Aging Neurosci",
      "key": "1107_CR46",
      "unstructured": "Bai X, Wu J, Zhang M, Xu Y, Duan L, Yao K, et al. DHCR24 knock-down induced Tau Hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 epitopes and inhibition of autophagy by overactivation of GSK3beta/mTOR signaling. Front Aging Neurosci. 2021;13:513605.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1080/15548627.2019.1598754",
      "author": "JA Thayer",
      "doi-asserted-by": "publisher",
      "first-page": "140",
      "journal-title": "Autophagy",
      "key": "1107_CR47",
      "unstructured": "Thayer JA, Awad O, Hegdekar N, Sarkar C, Tesfay H, Burt C, et al. The PARK10 gene USP24 is a negative regulator of autophagy and ULK1 protein stability. Autophagy. 2020;16:140–53.",
      "volume": "16",
      "year": "2020"
    }
  ],
  "reference-count": 47,
  "references-count": 47,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-022-01107-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Genetic analysis of the PCSK9 locus in psychological, psychiatric, metabolic and cardiovascular traits in UK Biobank"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "30"
}